ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Codexis Narrows Biocatalysis Focus

by Ann M. Thayer
November 18, 2013 | APPEARED IN VOLUME 91, ISSUE 46

Codexis has decided to focus exclusively on developing biocatalysts for making pharmaceuticals and specialty chemicals. It is winding down its cellulase enzymes business after failing to find a new transaction or partner in light of slow prospects for the expansion of the cellulosic ethanol industry. Earlier in the year, Codexis also stopped development of detergent alcohols.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment